Cytocom Inc. Announces Completed Merger with Cleveland BioLabs
FORT COLLINS, Colo., July 28, 2021 /PRNewswire/ — Cytocom Inc. (“Cytocom” or “Company”), a leading biopharmaceutical company creating next-generation therapies that focus on immune homeostasis, today announced the completion of its merger with Cleveland…
